Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,267 | -7,722 | -26,505 | -25,618 | 17,576 |
| Depreciation Amortization | 47 | 2,022 | 1,779 | 1,313 | 751 |
| Accounts receivable | N/A | 301 | 178 | 176 | 257 |
| Accounts payable and accrued liabilities | -222 | -1,917 | -1,345 | -157 | -849 |
| Other Working Capital | -841 | -8,164 | -5,693 | -2,803 | -2,722 |
| Other Operating Activity | 3,990 | -41,170 | -11,689 | -3,380 | -31,268 |
| Operating Cash Flow | $-8,293 | $-56,650 | $-43,275 | $-30,469 | $-16,255 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 900 | 14,080 | 14,102 | 14,680 | -37 |
| Investing Cash Flow | $900 | $14,080 | $14,102 | $14,680 | $-37 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -20 | -37,229 | -10,056 | -10,035 | -2,017 |
| Common Stock Issued | N/A | 90 | 65 | 65 | N/A |
| Other Financing Activity | 0 | 22,901 | 0 | 0 | 0 |
| Financing Cash Flow | $-20 | $-14,238 | $-9,991 | $-9,970 | $-2,017 |
| Exchange Rate Effect | 0 | -12 | -26 | -62 | -13 |
| Beginning Cash Position | 36,996 | 93,816 | 93,816 | 93,816 | 93,816 |
| End Cash Position | 29,583 | 36,996 | 54,626 | 67,995 | 75,494 |
| Net Cash Flow | $-7,413 | $-56,820 | $-39,190 | $-25,821 | $-18,322 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,293 | -56,650 | -43,275 | -30,469 | -16,255 |
| Capital Expenditure | 0 | -625 | -807 | -229 | -37 |
| Free Cash Flow | -8,293 | -57,275 | -44,082 | -30,698 | -16,292 |